Overview of events

You can find all health policy events over the course of Germany’s Presidency of the Council of the European Union that concern the Federal Ministry of Health, its remit and the associated programme in our Events Calendar. Please note that some events are reserved for specific specialist groups and are not open to the general public.

Disclaimer in light of the current situation

Due to the COVID-19 pandemic, changes to events within the framework of Germany’s Presidency or their format may arise at short notice. All entries in the calendar are therefore subject to change.


Institutional programme online

Informal meeting of the Committee for Orphan Medicinal Products (COMP)

The Committee for Orphan Medicinal Products (COMP) is one of the EMA’s scientific committees. It is responsible for assessing applications for “Orphan Drug Status”, which should promote the development of medicinal products for rare diseases.

This event is  non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: European Medicines Agency


Associated programme hybrid

Big data, big deeds? Towards data-driven European health systems

On the occasion of the German Presidency of the Council of the European Union the German National Association of Statutory Health Insurance Funds will hold an online conference on Big Data in healthcare. The objective of the conference is to explore the potential for cooperation in Europe in the field of cross-border use of data to optimise healthcare provision and healthcare systems. The event will pay particular attention to the role of the EU and the potential contribution of health insurance systems in Europe. The conference supports the objective of the Federal Ministry of Health to use the German Presidency of the Council of the EU to pave the way for a European Health Data Space. Conference languages are English and German. #EU2020GKV

This event is public and organised by German National Association of Statutory Health Insurance Funds
.

More Information: GKV-Spitzenverband

Contact: politik@gkv-spitzenverband(dot)de


Institutional programme online

Meeting of Chief Medical Officers (CMO)

In light of the COVID-19 pandemic, during this EU Council presidency the traditional meeting of Chief Medical Officers will take place in form of a virtual meeting. Given the current situation, the issue of cross-border contact tracing will be addressed. In the context of COVID-19 measures, the heads of the EU member states’ national public health institutes will also be invited to the conference. The meeting will serve to exchange experiences and discuss strategies to improve and simplify cross-border contact tracing. Representatives of the EU Commission and the WHO Regional Office for Europe will be invited as guests.

This event is non-puplic and organized by the Robert Koch-Institute.


Events Brussels

Working Party on Public Health at Senior Level

The High-Level Working Group on Public Health (HLWG Health) deals with all EU topics in the field of public health. Chaired by the rotating presidency, the group consists of high-level representatives from the member states’ competent ministries. The HLWG provides the Presidency with an opportunity to set political priorities and thereby place certain topics at the centre of EU public health policy.

More Information: Working Party on Public Health, Working Party on Pharmaceuticals and Medical Devices (Council of the EU)


Events Brussels

Horizontal Working Party on Drugs

The Council’s Horizontal Working Party on Drugs (HDG) retains a general overview of all drug-related issues. It is the responsibility of the Presidency and the General Secretariat to ensure that the working party is also kept informed of all drug-related issues addressed in other council working groups. The Working Party not only discusses legislative proposals regarding drug policy, but also prepares EU positions for international bodies, for example within the framework of the UN.

More Information: Horizontal Working Party on Drugs (HDG) - Council of the EU


Institutional programme online

Informal meeting of the experts of the Coordination Group for Mutual Recognition (MRP) and Decentralised Procedures (DCP)

The role of the Coordination Group is to investigate all aspects connected with the authorisation to place a medicinal product on the market in two or more EU Member States. Every authorisation to place a medicinal product on the market covers a wide range of questions involving new applications, amendments, prolongations and pharmacovigilance activities. The Coordination Group examines when conflicts of opinion owing to potential serious risk to public health are expressed by Member States during the mutual recognition procedure or the decentralised procedures in relation to the assessment report or the product information for a specific medicinal product. The aim is to guarantee close cooperation between Member States. Agreeing on a unified position regarding assessment of medicinal products authorised in more than one Member States helps to avoid duplication of efforts.

This event is non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: Heads of Medicines Agencies (HMA)


Associated programme hybrid

Resilient health systems 2020

The conference takes up the experiences of the health care systems, which were made during the COVID-19 pandemic in Germany and in the EU. The main focus is on the consequences to be drawn and what could be learned from them. Thematically, the conference is oriented to the outpatient medical system in Germany. The topics addressed digital care approaches, the structure of self-governance, aspects of education and training, regional testing strategies for SARS-CoV-2 and linking public health services and European and national health institutions. The event will be organised as a digital conference, which will be broadcasted on Internet-platforms. It consists of panel discussions and several parallel specialist forums. Interested attendees can either follow the conference on the Internet or actively participate in the discussions. #HealSy20

This event is public and organised by the National Association of Statutory Health Insurance Physicians (KBV). 

More Information: Kassenärztliche Bundesvereinigung

Contact: Corina Glorius, cglorius@kbv(dot)de


Associated programme online

The 2nd Joint Meeting “Innovations in Healthcare” (INNO Meeting)

The INNO meeting stands for "INNOvations in healthcare" and was initiated against the background that in the life cycle of a drug several official expert groups provide scientific advice to the manufacturers of a product. These groups include the Scientific Advice Working Party, the EU Innovation Network, the Clinical Trail Facilitation and Coordination Group, the European Network of HTA, the Innovation Task Force and the SME Office of the EMA. The overall aim is to promote efficient cooperation between the regulatory authorities and the health technology assessment (HTA) organisations in advising industry with the aim of generating data relevant for both the approval and the HTA assessment. The common thematic priorities include the management of innovations, such as advanced therapy medicinal products (ATMPs), and the collection of register data and their usability in Europe.

This event is non public and organised by the Federal Joint Committee (G-BA) and the Institute for Quality and Efficiency in Health Care (IQWiG).

More Information: G-BA, IQWiG

Contact: Stephanie Said, stephanie.said@g-ba(dot)de, Alric Rüther, alric.ruether@iqwig(dot)de


Associated programme hybrid

For a healthy EU: Strengthening of the security of supply and pharmaceutical production in Europe

Taking place in the context of the Germany’s Presidency of the Council of the EU on October, 7th 2020, the digital event aims to introduce and present best practice models with regards to shortages of supply of pharmaceutical products, as well as to enable an exchange of experiences with the respective chosen approaches / methods of resolution. Moreover, a process shall be initiated for a discussion on whether, and if so by which measures, the pharmaceutical production in the EU can be strengthened further, and to what extent different collective efforts for the fortification of the production of pharmaceuticals and APIs have good prospects. In addition to Federal Health Minister Jens Spahn, who will open the conference, participants include Thierry Breton, EU Commissioner for Internal Market and Services, Prof. Dr. Karl Broich, President, Federal Institute for Drugs and Medical Devices and Tiemo Wölken, MEP.

This event is public and organised by ProGenerika.

More Information: progenerika

Contact: Bork Bretthauer, info@progenerika(dot)de


Institutional programme online

Meeting of the European Union Competent Authorities for Medical Devices (CAMD) Expert Group

The European Union (EU) Competent Authorities for Medical Devices (CAMD) network was created to improve cooperation and communication between the European medical device authorities and thus the risk assessment and monitoring of medical devices in Europe. CAMD is an umbrella group under which the national competent authorities in the EU closely work together to further improve the fulfilment of common tasks in the European internal market for medical devices. To achieve these objectives, the CAMD coordinates e.g. joint action projects to help EU member states fulfil their tasks and to develop better mechanisms for cooperation, coordination and distribution of tasks.

This event is non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: Competent Authorities for Medical Devices (CAMD)


Events MoH presence

EU National Drug Coordinators Meeting

A meeting of national drug coordinators at the invitation of the current Presidency of the Council of the European Union. In the context of Germany’s Presidency of the Council of the EU, the drug coordinators will exchange ideas on different aspects of a modern drugs policy with particular emphasis on vulnerable groups. Together they will discuss aspects from the fields of prevention, early intervention and damage mitigation, and will present individual "best practice" models. This agenda takes up the themes of Resolution 61/7 of the Commission on Narcotic Drugs (CND) and highlights the specific challenges in terms of drugs policy posed by the current COVID-19 crisis.

This is a non-public event.

More Information: Europäische Drogen- und Suchtpolitik (German)


Institutional programme online

Meeting of the Working Group of Enforcement Officers (WGEO)

The Heads of Medicines Agencies Working Group of Enforcement Officers (HMA WGEO) is engaged in the fight against falsified medicinal products for human and veterinary use in the legal and illegal supply chain. This international and interdisciplinary network of drug regulatory, law enforcement and customs authorities discusses and provides training on concrete falsification cases and general approaches. The main goal of sharing information on falsified and stolen medicinal products via the internal Rapid Alert System is to ensure health protection.

This event is non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: Heads of Medicines Agencies (HMA) 


Institutional programme online

CMDv / CVMP Meeting

This event brings together the two main bodies that regulate veterinary medicinal products in the European Economic Area: the Coordination Group for Mutual Recognition and Decentralized Procedures - Veterinary (CMDv) and the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA).
This meeting within the framework of Germany’s Presidency of the Council of the EU allows the committees to discuss fundamental issues of common interest that go beyond the processing of product-specific assessment procedures.

This event is non-public and organized by the Federal Institute for Vaccines and Biomedicines and the Federal Office of Consumer Protection and Food Safety.


Institutional programme online

Pharmacovigilance Risk Assessment Committee (PRAC), the Committee for Advanced Therapies (CAT) and the Pediatric Committee (PDCO) Meeting

Three committees of the European Medicines Agency (EMA) will meet at this event: the Pharmacovigilance Risk Assessment Committee (PRAC), the Committee for Advanced Therapies (CAT) and the Pediatric Committee (PDCO). This meeting within the framework of Germany’s Presidency of the Council of the EU allows the committees to discuss fundamental issues of common interest that go beyond the processing of product-specific assessment procedures at the EMA.

This event is non-puplic and organized by the Federal Institute for Vaccines and Biomedicines.


Events MoH presence

World Health Summit 2020

In recent years, Germany has strengthened its commitment to global health, leveraging its G7 and G20 presidencies and lending support to multilateral and bilateral health partnerships. It has also become one of the strongest supporters of the World Health Organization and other international agencies. This presents a significant opportunity to help identify measures all EU members can implement in areas such as development, health, research, environment and trade in order to achieve Sustainable Development Goal 3. In light of this, the Federal Ministry of Health, together with its trio partners Portugal and Slovenia, will hold a moderated panel discussion of the health ministers. The aim is to assess the progress achieved so far on the initiative to strengthen the EU’s role in global health that was officially launched under Finland’s Council Presidency.

This event is public.

More Information: Wold health Summit 2020

Contact: BMG - Referat Z23 "Globale Gesundheit", Z23@bmg.bund(dot)de


Institutional programme online

Meeting of the Expert of European Medicines Agencies Co-operation of Legal and Legislative Issues (EMACOLEX)

EMACOLEX (European Medicines Agencies Cooperation on Legal and Legislative Issues) is an informal working group set up by the Heads of Medicines Agencies (HMA) to promote the cooperation on legal matters among lawyers working in European licensing authorities.

EMACOLEX supports the efforts of the European Medicines Regulatory Network (EMRN) to safeguard public and animal health protection by providing a dialogue and discussion platform for lawyers and other staff of licensing authorities involved in legal matters.

EMACOLEX aims to ensure legal assistance to the EMRN and the individual competent national authorities. EMACOLEX is chaired by the current Presidency.

This event is non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: Heads of Medicines Agencies (HMA)


Events MoH online

Meeting of Directors for Pharmaceutical Policy of the European Health Ministries

Meeting of the directors for pharmaceutical policy of the European health ministries to discuss and align ideas to advance public health.


Events MoH online

Meeting of the Network of Competent Authorities for Pricing and Reimbursement : New gene therapies and real world evidence – how can we make best use of it?

The objective of this meeting is to discuss the significance of real world evidence in the (benefit) assessment of gene therapies and the connection with innovative reimbursement schemes. It will focus on identifying potential similarities with the marketing authorisation process of the European Medicines Agency (EMA) to initiate early on long-term cooperation between EMA and the health technology assessment (HTA) institutions with regard to data requirements.

This is a non-public event.


Events MoH presence

Interprofessional collaboration in healthcare

Interprofessional collaboration in healthcare is a topic that must be considered throughout Europe, because even though health care is a core national task, the Member States of the EU face similar challenges. Care provision structures are constantly becoming more professional and complex, yet, despite digitalisation and technology, this does not lead to a reduction in the number of health care tasks. Additionally, many healthcare professions are already experiencing a shortage of skilled personnel. Interprofessional collaboration is the only way to successfully provide health care. Here, clear differences exist between the different EU Member States. This event will take a look at other EU countries and find out what we can learn from one another.

This is a non-public event.


Associated programme hybrid

Health Innovation – the European Health Data Space and Real-World Evidence

The COVID-19 pandemic shows that real-world evidence generation has become even more crucial as data collected in medical practice would not only inform health systems and their resources, but also inform the development of medicines for the benefit of patients. The EU’s data strategy and proposed creation of a European Health Data Space offer the opportunity to harness the potential of real-world data through cross border collaboration with a view to enabling sustainable and early patient access to innovative technologies. This approach is also particularly relevant in view of the EU’s commitment to the Beating Cancer Plan. This Conference will consider how a multi-stakeholder EU Learning Network could be established to foster learnings from the use of real-world evidence within the context of the European Health Data Space in order to inform deliberations between payers/HTA authorities and enable a learning system to bring the right treatment, for the right patient, at the right time. #rwe4decisions

This event is public and organised by the Multi-Stakeholder Group RWE4Decisions.

Contact: RWE4Decisions Secretariat, secretariat@rwe4decisions(dot)com


Events MoH presence

High-Level Conference "Digital Health 2020 – EU on the Move"

The High-Level Conference "Digital Health 2020 – EU on the Move" aims to advance a topic that is central to shaping our future: ensuring the science-based, legally sound and values-based use of big data and artificial intelligence as a foundation for providing healthcare to the European citizens. As an economic, scientific and values-based community, the European Union advocates a sensitive and patient-oriented use of health data. The handling of health data in the context of pandemic incidents is also to be discussed. The conference will bring together up to 450 invit-ed decision-makers from politics, science, business, medicine and civil society and, with its innovative formats, should provide a place of communication and exchange on how best to attain a joint EU health data space. Selected items of the programme will be published via stream.

Contact: Ministry of Health, EU2020@bmg.bund(dot)de


Events MoH presence

Meeting of the european eHealth Network

The objectives of the eHealth network according to Article 14 of the EU Patient Mobility Directive is to work towards delivering sustainable economic and social benefits of European eHealth systems and services and interoperable applications, with a view to achieving a high level of trust and security, enhancing continuity of care and ensuring access to safe and high-quality healthcare. The eHealth Network is thus a central platform for cooperation on digital health at EU level, contributing to the European health data space and also undertaking important work to align digital solutions in fighting the Covid-19 pandemic.

This is a non-public event.

More Information: eHealth Network


Associated programme hybrid

Doctors going digital: How to future-proof skills

What digital skills and abilities does the physician need in light of the increasing prevalence of telemedicine apps or the use of artificial intelligence in medicine? To tie in with Germany’s presidency of the Council of the European Union, the physicians’ organisations that comprise the Standing Committee of European Doctors (CPME) and the German Medical Association, along with an audience of experts, would like to address the question of what digital skills the physician must have in order to be able to safely make use of the possibilities offered by new technology in a way that benefits the patient. Related to this is also the question of how to impart the corresponding skills and abilities when faced with medical degree courses that are already condensed or in the case of doctors who are already practising medicine. The conference will take place on 20 November 2020 from 09:00 to 12:00 in Berlin. #CPMEdigitalskills

This event is public and organised by the German Medical Association (BÄK) and the Standing Commitee of European Doctors (CPME).

More Information: Bundesärztekammer

Contact: international@baek(dot)de


Associated programme hybrid

Digital Health: NOW! Acting jointly for a digitised and value-based healthcare in the EU

Demographic development, structural factors, personnel shortage: The healthcare system in the EU faces major challenges. At the same time, the digitisation of society changes citizens’ expectations of modern care creating new opportunities for a healthcare system that is interconnected and digitally supported. The handling of the COVID-19 pandemic has shown how important it is to ensure a rapid transition to shared health care systems. Alternatives for face-to-face diagnoses and therapies had to be developed quickly. Many solutions have made it clear that digital medicine (i.e. telemedicine, interconnectedness, automatic integration and AI-supported use of data) enhances and strengthens healthcare. The highest level of medical expertise and cross-border cooperation in care must be available in every part of Europe. The overarching goal is a value-based healthcare system for every citizen in the EU. #digitalhealthNowEU

This event is public and organised by German Telemedicine Association (DGTelemed), the Innovation Center Digital Medicine at the Uniklinik RWTH Aachen (IZDM) and the ZTG Centre for eHealth and Telemedicine.

More Information: Digital Health NOW 2020

Contact: Anna Wewer, info@digitalhealth-now(dot)eu


Institutional programme online

HMA Working Group of Quality Managers (WGQM) Meeting

The HMA Working Group of Quality Managers (WGQM) is a working group of quality managers of the national competent authorities who are responsible for the regulation of medicinal products for human in the European Economic Area. They meet biannually for an exchange on quality assurance measures with respect to official working procedures and to steer and promote benchmarking procedures.

This event is  non-puplic and organized by the Federal Institute for Vaccines and Biomedicines.


Associated programme hybrid

Personalised medicine in oncology: Benefits for cancer patients, society and health systems in Germany and Europe

Together with the European Commission and the initiative Europe’s Beating Cancer Plan, Germany would like to use its Council Presidency to drive forward the fight against cancer in Europe. The aim of the event is not only to continuously raise awareness of medical progress in the area of oncology, but also to engage in a dialogue about the ways in which innovation is received in the everyday life of patients and how healthcare systems can cope with it. Using practical examples, innovative therapeutic options in oncology will be presented and then the added value for society as well as the associated challenges will be discussed.

This event is public and organised by the German Association of Research-Based Pharmaceutical Companies (vfa).

Contact: Katja Standke, k.standke@vfa(dot)de


Associated programme hybrid

Digital fundamental rights in the EU: A digital code of ethics for a new era

The event addresses the issue of the ethical, legal and social framework conditions for the use of health data. In view of the ongoing digital transformation in the health care system, a clear European idea is needed with regard to the conditions under which health data can be used for research purposes and to control and supervise the management of health care. To deal with the COVID-19 pandemic, there are digital data collection and evaluation methods available that concern ethical and data privacy regulations.  These potential conflicts and solutions for the optimal use of data require a thorough review and clarification. The aim of the event is therefore to focus on the examination of and solutions to cross-border problems in terms of the promotion of digital transformation in the health care system. The keynotes and discussions at the event present a contribution from a health insurance fund perspective on the reception of a "code of conduct". #EU2020TK

This event is public and organised by Techniker Krankenkasse (TK).

More Information: Die Techniker

Contact: Hardy Müller, hardy.mueller@tk.de


Events MoH presence

21st century challenges for the eHealth National Competence Centers in Europe

The event offers a special forum for the European competence centres for digital health to discuss current challenges and trends in the digitalisation of healthcare within Europe. The details of the event will be determined by the further development of the European eHealth Digital Service Infrastructure and the intensification of European cooperation in the area of technical standards and best practices for digital health. The event’s goal is to come together with European partners to elaborate a joint vision for a digital and cross-linked healthcare system in Europe.

This is a non-public event.

More Information: gematik (German)


Institutional programme online

Heads of Medicines Agencies (HMA) Meeting

The Heads of Medicines Agencies (HMA) is a network of the heads of the National Competent Authorities (NCA) whose organisations are responsible for the regulation of medicinal products for human and veterinary use in the European Economic Area.

They meet quarterly to discuss topics of strategic relevance together with representatives of the European Medicines Agency (EMA), the European Commission (EC) and the European Directorate for the Quality of Medicines (EDQM).

This event is  non-puplic and organized by the Federal Institute for Vaccines and Biomedicines.


Associated programme hybrid

To ensure the availability of medicine - a pan-European challenge

All Member States of the European Union discuss problems of ensuring the availability of medicines. The experience from the COVID-19 pandemic has increased the importance of these problems. This makes coordinated action at EU level more important. The German government put medicine shortages high on the agenda of its EU Council Presidency. The AOK, with over 26 million health-insured persons in Germany, will address these and other questions in a digital dialogue with representatives from German and European politics as well as from science. Speakers will be: Thomas Müller, head of department at the German Federal Ministery of Health on pharmaceutical and other issues, Jutta Paulus, Member of the European Parliament, Noel Wathion, Deputy Executive Director of the European Medicines Agency (EMA), Dr. Sabine Vogler, pharmaceutical economist at Gesundheit Österreich GmbH, Dr. Christa Wirthumer-Hoche, Austrian Medical Market Authority (AGES) and Martin Litsch, Chairman of the Federal Association of the AOK.

This event is puplic and organised by AOK-Bundesverband.

Contact: Tamara Marraffa, tamara.marraffa@bv.aok(dot)de


Events MoH online

The German genomics initiative "genomDE"

Genome sequencing is to be introduced into routine healthcare practice in Germany. The aim of the genome initiative “genomDE” is the use of clinical, phenotypic and genomic data in health care. New insights will flow into research. This knowledge-generating care concept is intended to elevate German health care to a new level. Furthermore, national activities will be connected with the European '1+ Million Genomes' Initiative. Both initiatives will be important for a common European data space. “genomDE” is part of the Federal Government’s Coalition Agreement, the HighTech Strategy 2025, the AI Strategy (2018) and the Data Strategy White Paper (2019), as well as the extensive digitalisation measures by the Federal Ministry of Health.The genome initiative “genomDE” will be presented in the context of national and European initiatives.

This is a non-public event.


Associated programme hybrid

Medicines for Future – How to ensure availability and access

The conference will discuss with a strong involvement of the heads of European medicines agencies the major challenges for a sustainable supply of both prescription and non-prescription medicines as well as other consumer health products. Special attention will be paid to issues such as medicines‘ shortages, real world data but also to the switch of medicines from prescription to non-prescription status.  Overarching theme in all areas is digitalisation in health care.

This event is public and organised by the German Medicines Manufacturers' Association (BAH).

Contact: Friederike Gruner-Gramstadt, gruner@bah-bonn(dot)de

More Information: German Medicines Manufacturers' Association


Associated programme presence

Medicines shortages: Giving up? Finding solutions!

Medicines shortages have been part of everyday life in Europe for some years now. The reasons for this are complex and lie, for instance, in the structures of the highly globalised and specialised pharmaceutical production. For certain active ingredients there are currently only a few manufacturers worldwide. Loss of production or quality problems in a single plant could then be enough to endanger the supply of medicines to patients in Europe. The outbreak of the COVID-19 pandemic has now exacerbated this situation and ignited a new debate at EU level. Together with a high-level panel consisting of Members of the European Parliament, members of the European Commission and representatives of international pharmacists' associations and the pharmaceutical industry, ABDA - Federal Union of German Associations of Pharmacists would like to shed light on the challenges surrounding this problem and discuss possible solutions. #medicinesshortages

This event is public and organised by the Federal Union of German Associations of Pharmacists (ABDA).

Contact: Dr. Jens Gobrecht, europa@abda(dot)de


Events Brussels presence

Employment, Social Policy, Health and Consumer Affairs Council (EPSCO)

The Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) of the EU ministers of health will meet in Brussels on 2 December 2020 at the invitation of German Federal Minister Jens Spahn. In the public health area, the Council adopts legislation on healthcare-related topics together with the EU Parliament while preserving the competences of each member state, e.g. with the aim of improving the health of EU citizens or EU rapid response capacities.

More Information: Employment, Social Policy, Health and Consumer Affairs Council configuration (EPSCO) (European Council)

 

 


Institutional programme online

Meeting of the Working Group of Communication Professionals (WGCP)

The Working Group of Communications Professionals (WGCP) was established in 2007 by the Heads of Medicines (HMA) to actively shape and expand communications expertise across the network. To this end, the WGCP shares good practice, coordinates communications across the HMA network in a crisis and helps develop and improve the HMA’s website. In addition, it fosters the professional communication between the HMA and its stakeholders (for instance patients, physicians, veterinarians, pharmaceutical industry, and other healthcare professionals) and the general public (including the media).

This event is non-puplic and organized by the Federal Institute for Drugs and Medical Devices.

More Information: Heads of Medicines Agencies (HMA)

 

 

 


Associated programme hybrid

BVMed Convention on Hygiene

The BVMed Hygiene Convention addresses important topics and issues in the field of hygiene and infection control in hospitals, nursing homes and other medical facilities. A pandemic such as the COVID-19 pandemic, which has affected the entire EU since early 2020, highlights the need for effective infection control. Strict adherence to basic preventive measures protects against the spread of infections and thus saves lives. In addition to this topic, this year's BVMed Hygiene Convention will focus on innovative, and in particular digital, support options in the EU: Which offers in the field of hygiene and infection protection are already available today? Where would digital offers be particularly useful? How can digital communication between sectors in the healthcare system ensure better care outcomes? Which innovative and alternative concepts – also within the professional field of the nurse – are there beyond that to effectively and efficiently implement infection control? #RechtaufHygiene

This event is public and organised by the German Medical Technology Association (BVMed).

Contact: Lena Geppert, geppert@bvmed(dot)de

More Information: bvmed

Contact